NUTEX Investments Public Limited Company (BUSE: NUTEX)
Health Care · Pharmaceuticals · HU
Ft12.40
+3.33% today · -23.5% 1Y
NUTEX Investments Public Limited Company (BUSE: NUTEX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $6.01M.
Over the last twelve months the share price has lost 23.5%, trading between 11.00 and 17.35.
Tweenvest scores NUTEX Investments Public Limited Company across four factors: quality 51/100, value 56/100, growth 49/100. Its strongest factor is value.
NUTEX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.01M
- Revenue (TTM)
- $1.44K
- P/E
- 2.12
- EPS
- 5.86
- Dividend yield
- —
- Beta (5Y)
- 0.98
- 52-week high
- Ft17.35
- 52-week low
- Ft11.00
- Avg volume (3M)
- —
- Shares outstanding
- 158.45M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Phong Phu Pharmaceutical Joint Stock CompanyHNX: PPP | $6.16M | ₫18,200.00 | -1.62% |
| Q/C Technologies, Inc.NasdaqCM: QCLS | $6.13M | $0.63 | -15.51% |
| ECS Botanics Holdings LtdASX: ECS | $6.12M | AU$0.01 | +10.00% |
| Blueberries Medical Corp.CNSX: BBM | $6.10M | CA$0.02 | -25.00% |
| Cardiac Biotech Solutions Inc.OTCPK: CBSC | $5.97M | $0.04 | +11.29% |
| Sonoma Pharmaceuticals, Inc.NasdaqCM: SNOA | $5.84M | $1.22 | -0.81% |
| Gelteq LimitedNasdaqCM: GELS | $5.83M | $0.56 | +7.44% |
| Invex Therapeutics LtdASX: IXC | $5.81M | AU$0.11 | -4.35% |
Figures last refreshed Oct 4, 2026.